Gossamer Bio, 5% 1jun2027, USD (Conv.) (FIGI BBG00TZ4H6H9, WKN A28X9H)
国内債券, 転換社債, トレース適格, Senior Unsecured
国内債券, 転換社債, トレース適格, Senior Unsecured
|
Gossamer Bio is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
161 443
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡